Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.10.2015 | Original Article | Ausgabe 5/2015

European Surgery 5/2015

Galectin-3 as a potential biomarker in colorectal cancer?

Zeitschrift:
European Surgery > Ausgabe 5/2015
Autoren:
MD S. Kamali, MD E. Yilmaz, MD E. Sivrikoz, MD M. O. Erturk, MD G. H. Kamali, T. S. Sivrikoz, MD H. Guven

Summary

Background

Colorectal cancer incidence is inclining in the past decades, and diagnosis relies mainly on colonoscopic screening. Galectin-3 is recently shown to be associated with colorectal cancer. This study aimed to correlate serum galectin-3 levels with pathologically proven colorectal cancer.

Methods

All adult patients diagnosed with colorectal cancer in our institution from January to March 2013 were included in this prospective, observational study. During the same period, a control group with normal colonoscopic findings were included. After inclusion into the study, blood samples were collected from all participants. Serums obtained from the samples were stored at − 20 °C. Galectin-3 levels in blood samples were measured with an in vitro cantitative enzyme-linked immunosorbent assay (ELISA).

Results

Mean age was 62.7 years (range 29–85; standard deviation (SD): 14.8), mean body mass index (BMI) was 26.4 (21.4–42.4; SD: 4.5). Obesity (BMI ≤ 30), advanced age (≥55 years), and male gender were not significantly different among study groups (p > 0.05). In the colorectal cancer group mean galectin-3 levels were significantly elevated as compared to their control group counterparts (125.2 ± 19.1 vs. 23.0 ± 10.2, p < 0.001).

Conclusions

Galectin-3 levels were found significantly increased in colorectal cancer patients when compared with healthy controls. Further research is warranted to investigate the prognostic potential of galectin-3 in colorectal cancer.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 5/2015

European Surgery 5/2015Zur Ausgabe